NON-INVASIVE TOOLS FOR CVD SCREENING AND MONITORING
Dr Hadi Afsharan,
Research Fellow
University of Western Australia &
Harry Perkins Institute of Medical Research,
Perth, Western Australia
RESEARCHER PROFILE
Filmed in Perth, Australia | November 2025
Dr Hadi Afsharan is a Research Fellow Cardiovascular Science & Diabetes at the Harry Perkins Institute of Medical Research; is a translational research and innovation fellow in medical technologies at The University of Western Australia, holding dual titles as Translational Fellow and Innovation Fellow within UWA’s Medical School and the FHRI (Future Health Research and Innovation) program.
He earned his PhD in Biomedical Engineering from UWA in 2023, with a thesis entitled Development of Polarisation-Sensitive Optical Coherence Tomography for Application in Medical Diagnosis, which introduced a pioneering non-invasive imaging method for detecting hypertension and diabetes by analysing retinal blood vessel wall birefringence with exceptional sensitivity and specificity.
Hadi leads several translational research projects, including AI-based retinal biomarkers for coronary artery disease screening, low-cost imaging technologies for heart disease detection in remote communities, and radar-based non-contact measurement of jugular venous pressure, all supported by over $1.8 million in competitive funding from FHRI and UWA.
Source: Supplied
https://orcid.org/0000-0001-7874-2766
-
Dietary Interventions Influencing Neurological Outcomes
With over a decade of experience as a dietitian and nutritionist, Carolina Blagojevic Castro specialises in providing personalised dietary guidance and customised meal planning tailored to meet each client’s unique health needs. She is known for her engaging and educational presentations on topics related to health and nutrition, sharing practical, evidence-based insights with both community groups and professional audiences.
-
Novel forms of brain stimulation & psychedelic assisted psychotherapy
Professor Paul Fitzgerald is the Head of the School of Medicine and Psychology at the Australian National University. He is an academic psychiatrist with a MBBS degree, Masters of Psychological Medicine and research PhD. He has conducted an extensive range of experimental studies and clinical trials, focused on the development of novel treatment options for patients with mental health conditions such as depression, schizophrenia, obsessive compulsive disorder, PTSD, autism and Alzheimer’s disease.
-
Personalised approaches to lung therapy
Dr. Adams’ research focus is on lung cancer, which is the deadliest of all cancers worldwide. He is working towards developing personalised approaches to pinpoint a therapy that is going to be most effective for the person with that disease. Dr. Adams’ research is focusing on chemotherapy and targeted therapy, and he is trying to identify upfront which of those tumours are likely to be resistant to the therapy. He then identifies strategies that will resensitize or increase the sensitivity of the tumour to the standard of care that is targeted therapy or chemotherapy.
